New insights into paroxysmal nocturnal hemoglobinuria

References

• Takeda J, Miyata T, Kawagoe K, et al. Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria. Cell 1993;73(4): 703–711.
   PubMed Web of Science ®Google Scholar
• Hillmen P, Lewis SM, Bessler M, et al. Natural history of paroxysmal nocturnal hemoglobinuria. N Engl J Med 1995; 333(19):1253–1258.
   PubMed Web of Science ®Google Scholar
• Hillmen P, Young NS, Schubert J, et al. The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria. N Engl J Med 2006;355(12):1233–1243.
   PubMed Web of Science ®Google Scholar
• Bessler M, Mason PJ, Hillmen P, et al. Paroxysmal nocturnal haemoglobinuria (PNH) is caused by somatic mutations in the PIG-A gene. EMBO J 1994;13(1):110–117.
   PubMed Web of Science ®Google Scholar
• Nagarajan S, Brodsky RA, Young NS, et al. Genetic defects underlying paroxysmal nocturnal hemoglobinuria that arises out of aplastic anemia. Blood 1995;86(12):4656–4661.
   PubMed Web of Science ®Google Scholar
• Pramoonjago P, Pakdeesuwan K, Siripanyaphinyo U, et al. Genotypic, immunophenotypic and clinical features of Thai patients with paroxysmal nocturnal haemoglobinuria. Br J Haematol 1999;105(2):497–504.
   PubMed Web of Science ®Google Scholar
• Nafa K, Mason PJ, Hillmen P, et al. Mutations in the PIG-A gene causing paroxysmal nocturnal hemoglobinuria are mainly of the frameshift type. Blood 1995;86(12):4650–4655.
   PubMed Web of Science ®Google Scholar
• Yamada N, Miyata T, Maeda K, et al. Somatic mutations of the PIG-A gene found in Japanese patients with paroxysmal nocturnal hemoglobinuria. Blood 1995;85(4):885–892.
   PubMed Web of Science ®Google Scholar
• Chen R, Nagarajan S, Prince GM, et al. Impaired growth and elevated fas receptor expression in PIGA(+) stem cells in primary paroxysmal nocturnal hemoglobinuria. J Chin Invest 2000;106(5):689–696.
   PubMed Web of Science ®Google Scholar
• Rollins SA, Sims PJ. The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9. J Immunol 1990;144(9):3478–3483.
   PubMed Web of Science ®Google Scholar
• Medof ME, Kinoshita T, Silber R, et al. Amelioration of lytic abnormalities of paroxysmal nocturnal hemoglobinuria with decay-accelerating factor. Proc Natl Acad Sci USA 1985; 82(9):2980–2984.
   PubMed Web of Science ®Google Scholar
• Wilcox LA, Ezzell JL, Bernshaw NJ, et al. Molecular basis of the enhanced susceptibility of the erythrocytes of paroxysmal nocturnal hemoglobinuria to hemolysis in acidified serum. Blood 1991;78(3):820–829.
   PubMed Web of Science ®Google Scholar
• Rother RP, Bell L, Hillmen P, et al. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: A novel mechanism of human disease. JAMA 2005;293(13): 1653–1662.
   PubMed Web of Science ®Google Scholar
• Tailor A, Cooper D, Granger DN. Platelet—vessel wall interactions in the microcirculation. Microcirculation 2005; 12(3):275–285.
   Google Scholar
• Reiter CD, Wang X, Tanus-Santos JE, et al. Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat Med 2002;8(12):1383–1389.
   Google Scholar
• Moyo VM, Mukhina GL, Garrett ES, et al. Natural history of paroxysmal nocturnal haemoglobinuria using modern diag-nostic assays. Br J Haematol 2004;126(1):133–138.
   PubMed Web of Science ®Google Scholar
• Carmichael FJ, Ali AC, Campbell JA, et al. A phase I study of oxidized raffinose cross-linked human hemoglobin. Crit Care Med 2000;28(7):2283–2292.
   PubMed Web of Science ®Google Scholar
• Savitsky JP, Doczi J, Black J, et al. A clinical safety trial of stroma-free hemoglobin. Clin Pharmacol Ther 1978;23(1): 73–80.
   PubMed Web of Science ®Google Scholar
• Saxena R, Wijnhoud AD, Carton H, et al. Controlled safety study of a hemoglobin-based oxygen carrier, DCLHb, in acute ischemic stroke. Stroke 1999;30(5):993–996.
   PubMed Web of Science ®Google Scholar
• Tziros C, Freedman JE. The many antithrombotic actions of nitric oxide. Curr Drug Targets 2006;7(10):1243–1251.
   PubMed Web of Science ®Google Scholar
• Hugel B, Socie G, Vu T, et al. Elevated levels of circulating procoagulant microparticles in patients with paroxysmal nocturnal hemoglobinuria and aplastic anemia. Blood 1999; 93(10):3451–3456.
   PubMed Web of Science ®Google Scholar
• Grunewald M, Siegemund A, Grunewald A, et al. Plasmatic coagulation and fibrinolytic system alterations in PNH: Relation to clone size. Blood Coagul Fibrinolysis 2003;14(7): 685–695.
   PubMed Web of Science ®Google Scholar
• Maroney SA, Cunningham AC, Ferrel J, et al. A GPI-anchored co-receptor for tissue factor pathway inhibitor controls its intracellular trafficking and cell surface expression. J Thromb Haemost 2006;4(5):1114–1124.
   PubMed Web of Science ®Google Scholar
• Araten DJ, Nafa K, Pakdeesuwan K, et al. Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobi-nuria genotype and phenotype are present in normal individuals. Proc Natl Acad Sci USA 1999;96 (9):5209–5214.
   PubMed Web of Science ®Google Scholar
• Hu R, Mukhina GL, Piantadosi S, et al. PIG-A mutations in normal hematopoiesis. Blood 2005;105(10):3848–3854.
   PubMed Web of Science ®Google Scholar
• Rosti V, Tremml G, Soares V, et al. Murine embryonic stem cells without pig-a gene activity are competent for hematopoi-esis with the PNH phenotype but not for clonal expansion. J Chin Invest 1997;100(5):1028–1036.
   PubMed Web of Science ®Google Scholar
• Kawagoe K, Kitamura D, Okabe M, et al. Glycosylpho-sphatidylinositol-anchor-deficient mice: Implications for clo-nal dominance of mutant cells in paroxysmal nocturnal hemoglobinuria. Blood 1996;87(9):3600–3606.
   PubMed Web of Science ®Google Scholar
• Brodsky RA, Vala MS, Barber JP, et al. Resistance to apoptosis caused by PIG-A gene mutations in paroxysmal nocturnal hemoglobinuria. Proc Natl Acad Sci USA 1997;94(16): 8756–8760.
   PubMed Web of Science ®Google Scholar
• Hanaoka N, Kawaguchi T, Horikawa K, et al. Immunoselec-don by natural killer cells of PIGA mutant cells missing stress-inducible ULBP. Blood 2006;107 (3):1184–1191.
   PubMed Web of Science ®Google Scholar
• Inoue N, Izui-Sarumaru T, Murakami Y, et al. Molecular basis of clonal expansion of hematopoiesis in 2 patients with paroxysmal nocturnal hemoglobinuria (PNH). Blood 2006; 108(13):4232–4236.
   PubMed Web of Science ®Google Scholar
• Wang H, Chuhjo T, Yamazaki H, et al. Relative increase of granulocytes with a paroxysmal nocturnal haemoglobinuria phenotype in aplastic anaemia patients: The high prevalence at diagnosis. Eur J Haematol 2001;66(3):200–205.
   PubMed Web of Science ®Google Scholar
• Mukhina GL, Buckley JT, Barber JP, et al. Multilineage glycosylphosphatidylinositol anchor-deficient haematopoiesis in untreated aplastic anaemia. Br J Haematol 2001;115(2): 476–482.
   PubMed Web of Science ®Google Scholar
• Dunn DE, Tanawattanacharoen P, Boccuni P, et al. Parox-ysmal nocturnal hemoglobinuria cells in patients with bone marrow failure syndromes. Ann Intern Med 1999;131(6): 401–408.
   PubMed Web of Science ®Google Scholar
• Hernandez-Campo PM, Almeida J, Sanchez ML, et al. Normal patterns of expression of glycosylphosphatidylinositol-anchored proteins on different subsets of peripheral blood cells: A frame of reference for the diagnosis of paroxysmal nocturnal hemoglobinuria. Cytometry B Chin Cytom 2006; 70(2):71–81.
   PubMedGoogle Scholar
• Brodsky RA, Mukhina GL, Li S, et al. Improved detection and characterization of paroxysmal nocturnal hemoglobinuria using fluorescent aerolysin. Am J Chin Pathol 2000;114(3): 459–466.
   PubMed Web of Science ®Google Scholar
• Saso R, Marsh J, Cevreska L, et al. Bone marrow transplants for paroxysmal nocturnal haemoglobinuria. Br J Haematol 1999;104(2) :392–396.
   PubMed Web of Science ®Google Scholar
• Hegenbart U, Niederwieser D, Forman S, et al. Hematopoietic cell transplantation from related and unrelated donors after minimal conditioning as a curative treatment modality for severe paroxysmal nocturnal hemoglobinuria. Biol Blood Marrow Transplant 2003;9(11):689–697.
   PubMed Web of Science ®Google Scholar
• Takahashi Y, McCoy JP, Jr., Carvallo C, et al. In vitro and in vivo evidence of PNH cell sensitivity to immune attack after nonmyeloablative allogeneic hematopoietic cell transplan-tation. Blood 2004;103 (4) : 1383–1390.
   PubMed Web of Science ®Google Scholar
• Kawahara K, Witherspoon RP, Storb R. Marrow transplan-tation for paroxysmal nocturnal hemoglobinuria. Am J Hematol 1992;39(4):283–288.
   Google Scholar
• Hillmen P, Hall C, Marsh JC, et al. Effect of eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria. N Engl J Med 2004; 350(6):552–559.
   PubMed Web of Science ®Google Scholar